A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. J Yates, N Warren, D Reisman, B Sugden Proceedings of the National Academy of Sciences 81 (12), 3806-3810, 1984 | 923 | 1984 |
Compromised HOXA5 function can limit p53 expression in human breast tumours V Raman, SA Martensen, D Reisman, E Evron, WF Odenwald, E Jaffee, ... Nature 405 (6789), 974-978, 2000 | 630 | 2000 |
A Putative Origin of Replication of Plasmids Derived from Epstein-Barr Virus Is Composed of Two cis-Acting Components D Reisman, J Yates, B Sugden Molecular and cellular biology 5 (8), 1822-1832, 1985 | 587 | 1985 |
trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1 D Reisman, B Sugden Molecular and cellular biology 6 (11), 3838-3846, 1986 | 477 | 1986 |
c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif D Reisman, NB Elkind, B Roy, J Beamon, V Rotter Cell growth and differentiation 4, 57-57, 1993 | 304 | 1993 |
Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors B Roy, J Beamon, E Balint, D Reisman Molecular and cellular biology, 1994 | 169 | 1994 |
Inhibition of cell growth mediated by plasmids encoding p53 anti-sense. O Shohat, M Greenberg, D Reisman, M Oren, V Rotter Oncogene 1 (3), 277-283, 1987 | 158 | 1987 |
The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene D Reisman, V Rotter Nucleic acids research 21 (2), 345-350, 1993 | 155 | 1993 |
Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1. D Reisman, M Greenberg, V Rotter Proceedings of the National Academy of Sciences 85 (14), 5146-5150, 1988 | 132 | 1988 |
Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein MN Uittenbogaard, HA Giebler, D Reisman, JK Nyborg Journal of Biological Chemistry 270 (48), 28503-28506, 1995 | 108 | 1995 |
HER2 overexpression triggers an IL1α proinflammatory circuit to drive tumorigenesis and promote chemotherapy resistance S Liu, JS Lee, C Jie, MH Park, Y Iwakura, Y Patel, M Soni, D Reisman, ... Cancer research 78 (8), 2040-2051, 2018 | 93 | 2018 |
Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif. D Ronen, V Rotter, D Reisman Proceedings of the National Academy of Sciences 88 (10), 4128-4132, 1991 | 91 | 1991 |
Loss of heterozygosity and p53 expression in Pterygium D Reisman, JW McFadden, G Lu Cancer letters 206 (1), 77-83, 2004 | 89 | 2004 |
Transcriptional regulation of the p53 tumor suppressor gene D Reisman, WT Loging Seminars in cancer biology 8 (5), 317-324, 1998 | 84 | 1998 |
Transcriptional regulation of the p53 tumor suppressor gene in S-phase of the cell-cycle and the cellular response to DNA damage D Reisman, P Takahashi, A Polson, K Boggs Biochemistry research international 2012, 2012 | 81 | 2012 |
Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53 WT Loging, D Reisman Cancer Epidemiology Biomarkers & Prevention 8 (11), 1011-1016, 1999 | 81 | 1999 |
A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth Y Patel, N Shah, JS Lee, E Markoutsa, C Jie, S Liu, R Botbyl, D Reisman, ... Oncotarget 7 (14), 18295, 2016 | 76 | 2016 |
HOXB7 promotes malignant progression by activating the TGFβ signaling pathway S Liu, K Jin, Y Hui, J Fu, C Jie, S Feng, D Reisman, Q Wang, D Fan, ... Cancer research 75 (4), 709-719, 2015 | 70 | 2015 |
Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53 WT Loging, D Reisman Oncogene 18 (52), 7608-7615, 1999 | 53 | 1999 |
C/EBPβ participates in regulating transcription of the p53 gene in response to mitogen stimulation K Boggs, D Reisman Journal of biological chemistry 282 (11), 7982-7990, 2007 | 50 | 2007 |